Prognostic factors in clinical stage I non–small cell lung cancer
- 30 April 1999
- journal article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 67 (4), 927-932
- https://doi.org/10.1016/s0003-4975(99)00140-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trialsThe Lancet, 1998
- The Role of Multimodality Therapy in Locoregional Non-small Cell Lung CancerSurgical Oncology Clinics of North America, 1997
- Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer: An analysis in each pathologic stageThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrenceCancer, 1995
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- Surgically Curable “Early” Adenocarcinoma in the Periphery of the LungThe American Journal of Surgical Pathology, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.Journal of Clinical Oncology, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958